These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12816874)

  • 1. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.
    Steinbach D; Wittig S; Cario G; Viehmann S; Mueller A; Gruhn B; Haefer R; Zintl F; Sauerbrey A
    Blood; 2003 Dec; 102(13):4493-8. PubMed ID: 12816874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to chemotherapy and expression of the genes encoding the multidrug resistance-associated proteins MRP2, MRP3, MRP4, MRP5, and SMRP in childhood acute myeloid leukemia.
    Steinbach D; Lengemann J; Voigt A; Hermann J; Zintl F; Sauerbrey A
    Clin Cancer Res; 2003 Mar; 9(3):1083-6. PubMed ID: 12631611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
    Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ
    Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
    Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia.
    Plasschaert SL; de Bont ES; Boezen M; vander Kolk DM; Daenen SM; Faber KN; Kamps WA; de Vries EG; Vellenga E
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8661-8. PubMed ID: 16361551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children.
    Plasschaert SL; Vellenga E; de Bont ES; van der Kolk DM; Veerman AJ; Sluiter WJ; Daenen SM; de Vries EG; Kamps WA
    Leuk Lymphoma; 2003 Jan; 44(1):85-95. PubMed ID: 12691146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas.
    Rau S; Autschbach F; Riedel HD; Konig J; Kulaksiz H; Stiehl A; Riemann JF; Rost D
    Eur J Clin Invest; 2008 Feb; 38(2):134-42. PubMed ID: 18226047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chemotherapy resistance genes in outcome of neuroblastoma.
    de Cremoux P; Jourdan-Da-Silva N; Couturier J; Tran-Perennou C; Schleiermacher G; Fehlbaum P; Doz F; Mosseri V; Delattre O; Klijanienko J; Vielh P; Michon J
    Pediatr Blood Cancer; 2007 Mar; 48(3):311-7. PubMed ID: 16609945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.
    Rahgozar S; Moafi A; Abedi M; Entezar-E-Ghaem M; Moshtaghian J; Ghaedi K; Esmaeili A; Montazeri F
    Cancer Biol Ther; 2014 Jan; 15(1):35-41. PubMed ID: 24145140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples?
    Steinbach D; Friedrich J; Dawczynski K; Furchtbar S; Gruhn B; Wittig S; Zintl F; Sauerbrey A
    Leuk Lymphoma; 2005 Sep; 46(9):1357-63. PubMed ID: 16109615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
    Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
    Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
    Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
    Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma.
    Nies AT; König J; Pfannschmidt M; Klar E; Hofmann WJ; Keppler D
    Int J Cancer; 2001 Nov; 94(4):492-9. PubMed ID: 11745434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of peanut agglutinin binding in childhood acute lymphoblastic leukemia.
    Kaspers GJ; Veerman AJ; Van Wering ER; Van Der Linden-Schrever BE; Van Zantwijk CH; Van Der Does-Van Den Berg A; Pieters R
    Leukemia; 1996 Apr; 10(4):675-81. PubMed ID: 8618446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
    Ramakers-van Woerden NL; Pieters R; Hoelzer D; Slater RM; den Boer ML; Loonen AH; Harbott J; Janka-Schaub GE; Ludwig WD; Ossenkoppele GJ; van Wering ER; Veerman AJ;
    Med Pediatr Oncol; 2002 Jun; 38(6):379-86. PubMed ID: 11984797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
    Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
    Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
    Kool M; de Haas M; Scheffer GL; Scheper RJ; van Eijk MJ; Juijn JA; Baas F; Borst P
    Cancer Res; 1997 Aug; 57(16):3537-47. PubMed ID: 9270026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
    Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
    Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of Lung Resistance Protein mRNA at Diagnosis Predicts Poor Early Response to Induction Chemotherapy in Childhood Acute Lymphoblastic Leukemia.
    Bhatia P; Masih S; Varma N; Bansal D; Trehan A
    Asian Pac J Cancer Prev; 2015; 16(15):6663-8. PubMed ID: 26434891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.